Navigation Links
Pradaxa Lawsuit Lawyers at Wright & Schulte LLC Disturbed by New Study Finding that Pradaxa Users Face Significantly Higher Risk of Bleeding Side-Effects
Date:8/12/2013

Columbus, OH (PRWEB) August 13, 2013

The Pradaxa lawsuit lawyers at Wright & Schulte LLC, an experienced law firm representing the victims of defective drugs, are disturbed by a new study which found that patients who use Pradaxa or other new blood thinners face a significantly higher risk of gastrointestinal bleeding compared to other treatments. The Pradaxa bleeding research, which was published in the journal Gastroenterology last month, analyzed data from 43 published studies involving 151,578 patients who were either treated with Pradaxa or another new blood thinner, or standard care. Overall, patients taking the new drugs, including Pradaxa, faced a 55% increased risk of experiencing gastrointestinal bleeding. The risk was higher among patients treated for venous thrombosis and acute coronary syndrome.
[gastrojournal.org/article
/S0016-5085%2813%2900290-4/fulltext,
Gastroenterology, July, 2013]

Wright & Schulte LLC is already representing plaintiffs in Pradaxa lawsuits, and continues to offer free legal consultations to alleged victims of Pradaxa bleeding side effects, including:

  •     Serious internal bleeding
  •     Intercranial brain bleeding
  •     Stomach and intestinal bleeding
  •     Kidneys and other organs bleeding
  •     Irreversible life threatening bleeding events
  •     Stroke
  •     Heart attack
  •     Severe allergic reaction
  •     Death

For more information on filing a Pradaxa lawsuit, or to arrange for a free legal consultation, please visit yourlegalhelp.com.

Pradaxa was approved in October 2010 to prevent stroke in people with atrial fibrillation. While concerns have mounted over the danger of Pradaxa bleeding side effects, the U.S. Food & Drug Administration (FDA) continues to maintain that the drug is as safe as warfarin, a blood thinner that has been in use for decades. However, warfarin bleeding can be stopped with the administration of vitamin K, while there is currently no easy method to stop Pradaxa bleeding. In fact, the Institute for Safe Medication Practices (ISMP) warned in January that Pradaxa patients may be nearly 5 times as likely to die when they experience internal bleeding compared to those treated with warfarin. Among other things, the ISMP pointed to the lack of an antidote for Pradaxa bleeding as contributing to the increased risk of death associated with the drug.
[fda.gov/Drugs/DrugSafety/ucm326580.htm; FDA, November 2, 2012]
[ismp.org/quarterwatch/pdfs/2012Q2.pdf, ISMP, January 13, 2013]

Court records indicate that 1,363 Pradaxa bleeding lawsuits are currently pending in a federal multidistrict litigation underway in U.S. District Court, Southern District of Illinois. The first trial in that litigation is expected to begin in August 2014. Plaintiffs in Pradaxa lawsuits claim that Boehringer Ingelheim failed to provide adequate warnings about the drug’s risk, and failed to warn about the lack of an antidote for Pradaxa bleeding. (IN RE: Pradaxa Product Liability Litigation, U.S. District Court, Southern District of Illinois, MDL No. 2385)

About Wright & Schulte LLC Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free Pradaxa lawsuit case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.

Contact: Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com

Read the full story at http://www.prweb.com/releases/2013/8/prweb10962575.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Approval of Safer Alternative to Pradaxa Delayed by FDA
2. Pradaxa Maker Working on Antidote Amid Pradaxa Bleeding Warnings
3. FDA: Dont Use Pradaxa Blood Thinner in Patients With Artificial Heart Valves
4. Pradaxa Side Effect Warning: Pradaxa Label to Warn Blood-Thinner Shouldn’t be Used in People with Mechanical Heart Valves, Bernstein Liebhard LLP Reports
5. Carey Danis & Lowe Issues an Update on the Pradaxa Multi-District Litigation No. 2385
6. Pradaxa Lawsuits Being Investigated by Bernstein Liebhard LLP, as Next Conference in Federal Pradaxa Litigation Set for January 10th
7. DrugRisk Announces New Pradaxa Health Warning From Australia
8. 176 Pradaxa Lawsuits Now Pending in Federal Litigation, Discovery Well Underway, Bernstein Liebhard LLP Reports
9. Pradaxa Side Effect Problems Continue, as New Report Finds Pradaxa Bleeding More Likely to Result in Death, Bernstein Liebhard LLP Reports
10. Bernstein Liebhard LLP Launches Pradaxa Lawsuit Website Providing Information on Mounting Pradaxa Litigation, Side Effects
11. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... NY (PRWEB) , ... May 27, 2016 , ... With ... intervention to walk, the demand for a sustainable product to aid in the rehabilitation ... and aid in the recovery of individuals with hemiplegia due to stroke. , Ekso ...
(Date:5/27/2016)... ... May 27, 2016 , ... In response ... many who are unaware of the plight of aphasia. In collaboration with the ... “Stroke Awareness” campaign. , The link between stroke and aphasia is relatively unknown, ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees in ... come courtesy of leaders in the nursing and health care industry. It also provides ... associations—namely Abilene Christian University. , As the nursing industry is coming out of ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... Despite last ... meeting, expect Janet Yellen and company to wait until March 2017 for an interest ... University’s J. Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) ...
(Date:5/26/2016)... ... 2016 , ... Cabot Corporation, Pfizer, and 3M are responsible ... documents and SEC filings. A jury has returned a verdict of $32.8 ... Case No. BC588866, Los Angeles County, California. The jury awarded $22.8 million in ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... LifeScienceIndustryResearch.com adds "Ulcerative Colitis ... with comprehensive information on the therapeutic development for ... stages, therapeutics assessment by drug target, mechanism of ... type, along with latest updates, and featured news ... involved in the therapeutic development for Ulcerative Colitis ...
(Date:5/27/2016)... -- Hutchison China MediTech (Chi-Med) (HCM) ... highly lucrative global oncology and immunology markets. HCM ... or best-in-class tyrosine kinase inhibitor (TKI) drugs, some ... HCM,s profitable Chinese healthcare business continues to benefit ... of the mid-to-late-stage pipeline during 2016-17 (including US ...
(Date:5/26/2016)... India , May 26, 2016 ... drugs market growth is the emergence of new treatments. ... astaxanthin therapies for osteoarthritis treatment. The therapy is expected ... Moreover, Arthritis Research UK is conducting studies to develop ... arcOGEN study, where the genes involved in osteoarthritis are ...
Breaking Medicine Technology: